{42 (rivaroxaban 15 MG Oral Tablet) / 9 (rivaroxaban 20 MG Oral Tablet) } Pack — RxCUI 1549682
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Rivaroxaban: what it is, how it’s used, side effects, and interactions.
- Yes, rivaroxaban is a blood thinner, but it covers a pretty wide range of conditions. It's used to treat blood clots in the legs (DVT) and lungs (pulmonary embolism), prevent those...
- What exactly is rivaroxaban used for — is it just a blood thinner?
- It depends on the strength you've been prescribed. Certain higher-strength tablets need to be taken with food — food helps your body absorb enough of the medication. Lower-strength...
- Do I need to take rivaroxaban with food?
🕸️ Concept Web — How {42 (rivaroxaban 15 MG Oral Tablet) / 9 (rivarox... Connects
RxCUI 1549682 Generic pack · GPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Rivaroxaban
1114195IN
-
Rivaroxaban
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xarelto
1114199BN
-
Xarelto
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Rivaroxaban Oral Tablet
1114197SCDF -
Rivaroxaban Oral Product
1157968SCDG -
Rivaroxaban Pill
1157969SCDG -
Rivaroxaban Oral Tablet [Xarelto]
1114201SBDF -
Xarelto Oral Product
1186304SBDG -
Xarelto Pill
1186305SBDG -
Pack
746839DF -
Oral Product
1151131DFG - +1 more in this family
-
Rivaroxaban Oral Tablet
-
Clinical & branded drugs 8
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Rivaroxaban 15 MG Oral Tablet
1232082SCD -
Rivaroxaban 20 MG Oral Tablet
1232086SCD -
Rivaroxaban 15 MG
1232081SCDC -
Rivaroxaban 20 MG
1232085SCDC -
Rivaroxaban 15 MG Oral Tablet [Xarelto]
1232084SBD -
Rivaroxaban 20 MG Oral Tablet [Xarelto]
1232088SBD -
Rivaroxaban 15 MG [Xarelto]
1232083SBDC -
Rivaroxaban 20 MG [Xarelto]
1232087SBDC
-
Rivaroxaban 15 MG Oral Tablet
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
🔀 Generic ⇄ Brand Crosswalk
Generic (Clinical) Concepts
-
Rivaroxaban 15 MG Oral Tablet
SCD · 1232082 -
Rivaroxaban 20 MG Oral Tablet
SCD · 1232086 -
Rivaroxaban 15 MG
SCDC · 1232081 -
Rivaroxaban 20 MG
SCDC · 1232085 -
Rivaroxaban Oral Tablet
SCDF · 1114197 -
Rivaroxaban Oral Product
SCDG · 1157968 -
Rivaroxaban Pill
SCDG · 1157969
Brand-Name Concepts
-
Rivaroxaban 15 MG Oral Tablet [Xarelto]
SBD · 1232084 -
Rivaroxaban 20 MG Oral Tablet [Xarelto]
SBD · 1232088 -
{42 (rivaroxaban 15 MG Oral Tablet [Xarelto]) / 9 (rivaroxaban 20 MG Oral Tablet [Xarelto]) } Pack [Xarelto Kit]
BPCK · 1549683 -
Rivaroxaban 15 MG [Xarelto]
SBDC · 1232083 -
Rivaroxaban 20 MG [Xarelto]
SBDC · 1232087 -
Rivaroxaban Oral Tablet [Xarelto]
SBDF · 1114201 -
Xarelto Oral Product
SBDG · 1186304 -
Xarelto Pill
SBDG · 1186305 -
Xarelto
BN · 1114199
📦 FDA Products & Package NDCs
16 products · 54 package NDCs
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 62332-0683-10 | 100 BLISTER PACK in 1 CARTON (62332-683-10) / 10 TABLET, FI... | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0683-45 | 180 TABLET, FILM COATED in 1 BOTTLE (62332-683-45) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0683-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62332-683-60) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0683-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-683-91) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
🗃️ Sources & Limits
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.